ALNY

Alnylam Pharmaceuticals
ALNY

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$33.30B
EV
$33.34B
Shares Outstanding
131.79M
Beta
0.30

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$315.00
P/E 2025E
-
P/Revenue 2025E
11.52x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Alnylam Pharmaceuticals, Inc.

gainify
ALNY

Alnylam Pharmaceuticals, Inc.

ALNY

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of...

Sector

Healthcare

Industry

Biotechnology

CEO

Greenstreet, Yvonne

Employees

2,230

IPO Date

2004-06-01

Headquarters

675 West Kendall Street, Henri A. Termeer Square, Cambridge, Massachusetts, 02142, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved